Inventor · disambiguated record
Eugen Uhlmann
Also filed as: UHLMANN EUGEN · UHLMANN EUGEN DR
80 granted patents·24 pending applications·2,315 citations·filing 1984–2018
99Inventor score
Top patents by PatentIndex Score
104 records- 0198US9790494B2Multimeric oligonucleotide compounds having non-nucleotide based cleavable linkersTRANSLATE BIO MA INC·Filed 2015·Granted Oct 17, 2017·24 cites·20 claims
- 0298US7229974B2G cap-stabilized oligonucleotidesSANOFI AVENTIS DEUTSCHLAND·Filed 2001·Granted Jun 12, 2007·116 cites·32 claims
- 0397US7566703B2Semi-soft C-class immunostimulatory oligonucleotidesCOLEY PHARM GROUP INC·Filed 2005·Granted Jul 28, 2009·69 cites·26 claims
- 0497US6013639AG cap-stabilized oligonucleotidesHOECHST AG·Filed 1996·Granted Jan 11, 2000·165 cites·46 claims
- 0596US7615539B2Nucleic acid-lipophilic conjugatesCOLEY PHARM GROUP INC·Filed 2004·Granted Nov 10, 2009·76 cites·27 claims
- 0695US7956043B25′ CpG nucleic acids and methods of useCOLEY PHARM GROUP INC·Filed 2003·Granted Jun 7, 2011·82 cites·15 claims
- 0795US7795235B2Semi-soft c-class immunostimulatory oligonucleotidesCOLEY PHARM GMBH·Filed 2008·Granted Sep 14, 2010·35 cites·5 claims
- 0894US8304396B2Immunostimulatory nucleic acidsKRIEG ARTHUR M·Filed 2006·Granted Nov 6, 2012·38 cites·9 claims
- 0994US5276268APhosphinothricin-resistance gene, and its useHOECHST AG·Filed 1991·Granted Jan 4, 1994·475 cites·14 claims
- 1093US9580708B2Multimeric oligonucleotides compoundsUHLMANN EUGEN·Filed 2012·Granted Feb 28, 2017·16 cites·25 claims
- 1192US6348312B1Stabilized oligonucleotides and their useHOECHST AG·Filed 1994·Granted Feb 19, 2002·109 cites·67 claims
- 1291US8580268B2CpG oligonucleotide analogs containing hydrophobic T analogs with enhanced immunostimulatory activityDEBELAK HARALD·Filed 2007·Granted Nov 12, 2013·31 cites·7 claims
- 1390US8283328B2Immunostimulatory nucleic acidsKRIEG ARTHUR M·Filed 2003·Granted Oct 9, 2012·40 cites·11 claims
- 1489US9732340B2Multimeric oligonucleotides compounds having cleavable linkersTRANSLATE BIO MA INC·Filed 2015·Granted Aug 15, 2017·6 cites·18 claims
- 1589US9732341B2Methods of delivering multiple targeting oligonucleotides to a cell using cleavable linkersTRANSLATE BIO MA INC·Filed 2015·Granted Aug 15, 2017·6 cites·18 claims
- 1689US5874553APhosphonomonoester nucleic acids, process for their preparation, and their useHOECHST AG·Filed 1996·Granted Feb 23, 1999·89 cites·30 claims
- 1788US10093924B2Multimetric oligonucleotide compoundsTRANSLATE BIO MA INC·Filed 2017·Granted Oct 9, 2018·5 cites·22 claims
- 1888US5358857AMethod of preparing fusion proteinsGEN HOSPITAL CORP·Filed 1993·Granted Oct 25, 1994·75 cites·12 claims
- 1987US6046306APNA synthesis using an amino protecting group which is labile to weak acidsHOECHST AG·Filed 1997·Granted Apr 4, 2000·41 cites·5 claims
- 2086US6121434AG cap-stabilized oligonucleotidesAVENTIS PHARMA GMBH·Filed 1999·Granted Sep 19, 2000·53 cites·14 claims
- 2186US5227293AFusion proteins, their preparation and useGEN HOSPITAL CORP·Filed 1992·Granted Jul 13, 1993·71 cites·17 claims
- 2285US8198251B2Combination motif immune stimulatory oligonucleotides with improved activityVOLLMER JORG·Filed 2008·Granted Jun 12, 2012·11 cites·1 claims
- 2385US6472521B1Oligonucleotides for the inhibition of human eg5 expressionAVENTIS PHARMA GMBH·Filed 2000·Granted Oct 29, 2002·38 cites·12 claims
- 2485US6051408AGene and gene structure coding for an aminotransferase, and microorganisms which express this geneHOECHST AG·Filed 1997·Granted Apr 18, 2000·26 cites·4 claims
- 2584US7635769B2Oligoribonucleotide derivatives for specific inhibition of gene expressionSANOFI AVENTIS DEUTSCHLAND·Filed 2005·Granted Dec 22, 2009·9 cites·21 claims
- 2683US10844375B2Multimeric oligonucleotide compounds having non-nucleotide based cleavable linkersTRANSLATE BIO MA INC·Filed 2017·Granted Nov 24, 2020·1 cites·20 claims
- 2783US8349812B2Immune stimulatory oligoribonucleotide analogs containing modified oligophosphate moietiesADIUTIDE PHARMACEUTICALS GMBH·Filed 2008·Granted Jan 8, 2013·8 cites·4 claims
- 2883US5039796AProcess for 5'-phosphorylation of nucleic acidsHOECHST AG·Filed 1989·Granted Aug 13, 1991·19 cites·3 claims
- 2982US8772469B2Synthetic double-stranded oligonucleotides for specific inhibition of gene expressionUHLMANN EUGEN·Filed 2002·Granted Jul 8, 2014·26 cites·25 claims
- 3082US8188254B2C-class oligonucleotide analogs with enhanced immunostimulatory potencyUHLMANN EUGEN·Filed 2004·Granted May 29, 2012·19 cites·50 claims
- 3181US9200287B2Phosphate-modified oligonucleotide analogs with enhanced immunostimulatory activityUHLMANN EUGEN·Filed 2008·Granted Dec 1, 2015·5 cites·11 claims
- 3280US5817811AProcess for preparing substituted N-ethyglycine derivativesHOECHST AG·Filed 1996·Granted Oct 6, 1998·36 cites·15 claims
- 3380US5563050AAntisense oligonucleotides against HSV 1, and their preparationHOECHST AG·Filed 1994·Granted Oct 8, 1996·59 cites·6 claims
- 3479US10260071B2CpG oligonucleotide analogs containing hydrophobic T analogs with enhanced immunostimulatory activityCOLEY PHARM GMBH·Filed 2016·Granted Apr 16, 2019·2 cites·9 claims
- 3579US7897346B2Polyamide nucleic acid derivatives and agents, and processes for preparing themSANOFI AVENTIS DEUTSCHLAND·Filed 2009·Granted Mar 1, 2011·2 cites·4 claims
- 3679US6905820B2Polyamide nucleic acid derivatives, and agents and processes for preparing themAVENTIS PHARMA GMBH·Filed 2001·Granted Jun 14, 2005·7 cites·69 claims
- 3779US6037463AEnzymatic RNA molecules that cleave mutant N-RASHOECHST AG·Filed 1997·Granted Mar 14, 2000·51 cites·23 claims
- 3879US6033909AOligonucleotide analogs, their preparation and useHOECHST AG·Filed 1994·Granted Mar 7, 2000·32 cites·12 claims
- 3978US6875589B1Mini-proinsulin, its preparation and useHOECHST AG·Filed 1995·Granted Apr 5, 2005·32 cites·10 claims
- 4076US8268560B2Polymide nucleic acid derivatives, and agents and processes for preparing themUHLMANN EUGEN·Filed 2011·Granted Sep 18, 2012·2 cites·9 claims
- 4174US4832959APreparation of polypeptides having human γ-interferon activityHOECHST AG·Filed 1985·Granted May 23, 1989·34 cites·2 claims
- 4273US6121418APNA synthesis using a base-labile amino protecting groupHOECHST AG·Filed 1997·Granted Sep 19, 2000·14 cites·3 claims
- 4372US9382545B2CpG oligonucleotide analogs containing hydrophobic T analogs with enhanced immunostimulatory activityCOLEY PHARM GMBH·Filed 2013·Granted Jul 5, 2016·1 cites·8 claims
- 4472US6919441B2Polyamide-oligonucleotide derivatives, their preparation and useAVENTIS PHARMA GMBH·Filed 2001·Granted Jul 19, 2005·2 cites·8 claims
- 4572US6777544B2Polyamide nucleic acid derivatives and agents and processes for preparing themAVENTIS PHARMA GMBH·Filed 2001·Granted Aug 17, 2004·5 cites·78 claims
- 4671US7485421B2Polyamide-oligonucleotide derivatives, their preparation and useHOECHST GMBH·Filed 2004·Granted Feb 3, 2009·3 cites·4 claims
- 4769US9688988B2Modified TGF-beta oligonucleotide for use in a method of preventing and/or treating an ophthalmic diseaseISARNA THERAPEUTICS GMBH·Filed 2014·Granted Jun 27, 2017·1 cites·11 claims
- 4869US6326487B13 modified oligonucleotide derivativesAVENTIS PHARMA GMBH·Filed 1997·Granted Dec 4, 2001·42 cites·75 claims
- 4969US6127346APhosphonomonoester nucleic acids process for their preparation and their useHOECHST AG·Filed 1998·Granted Oct 3, 2000·26 cites·6 claims
- 5067US5696248A3'-modified oligonucleotide derivativesHOECHST AG·Filed 1995·Granted Dec 9, 1997·37 cites·21 claims
Showing the top 50 of 104 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Eugen Uhlmann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →